Serum tumor necrosis factor alpha associated with acute graft-versus-host disease in humans.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Transplantation

• Publication date

  1990-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007890-199009000-00033PMID 2402801
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antibodies to IFN-gamma prevent immunologically mediated intestinal damage in murine graft-versus-host reaction.

  1989cited by this paper
• Lymphotoxin, tumor necrosis factor, and gamma interferon are cytostatic for normal human keratinocytes.

  1989cited by this paper
• Cytokines as mediators of graft-versus-host disease.

  1988cited by this paper
• Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells

  1988cited by this paper
• Immunological reactivity and bioactivity of tumour necrosis factor.

  1988cited by this paper
• Regulation of growth and differentiation of human keratinocytes by type beta transforming growth factor and epidermal growth factor.

  1987cited by this paper
• Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

  1987cited by this paper
• Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria.

  1987cited by this paper
• Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes

  1987cited by this paper
• Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease

  1987cited by this paper
• Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha

  1987cited by this paper
• ELISA for quantitation of tumor necrosis factor-alpha in serum.

  1987cited by this paper
• Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1.

  1986cited by this paper
• Acute cutaneous graft-versus-host disease to minor histocompatibility antigens in a murine model. Evidence that large granular lymphocytes are effector cells in the immune response.

  1986cited by this paper
• Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

  1985cited by this paper
• Marrow transplantation from related donors other than HLA-identical siblings.

  1985cited by this paper
• Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo.

  1985cited by this paper
• Antiproliferative effects of recombinant alpha- and gamma-interferons on cultured human keratinocytes.

  1984cited by this paper
• Evidence of HLA-DR antigen biosynthesis by human keratinocytes in disease

  1984cited by this paper
• Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment.

  1983cited by this paper
• Immunological analysis of the skin in graft versus host disease.

  1982cited by this paper
• Tumour-necrosis factor from the rabbit. II. Production by monocytes.

  1978cited by this paper
• Bone-marrow transplantation (second of two parts).

  1975cited by this paper

• Endothelial Dysfunction after Hematopoietic Stem Cell Transplantation: A Review Based on Physiopathology

  2022cites this paper
• Dynamic Prediction of Acute Graft-versus-Host-Disease with Longitudinal Biomarkers

  2018cites this paper
• Composite biomarker panel for prediction of severity and diagnosis of acute GVHD with T-cell-depleted allogeneic stem cell transplants—single centre pilot study

  2017cites this paper
• Cytokine Profile of Engraftment Syndrome in Pediatric Hematopoietic Stem Cell Transplant Recipients.

  2016cites this paper
• Disease Severity and Mortality Can Be Independently Regulated in a Mouse Model of Experimental Graft versus Host Disease

  2015cites this paper
• Approaches for the prevention of graft-versus-host disease following hematopoietic cell transplantation.

  2015cites this paper
• Biomarkers of Graft-Versus-Host Disease

  2015cites this paper
• Current and emerging strategies for the prevention of graft-versus-host disease

  2014cites this paper
• Clinical Applications for Biomarkers of Acute and Chronic Graft vs. Host Disease

  2012cites this paper
• Clinical applications for biomarkers of acute and chronic graft-versus-host disease.

  2012cites this paper
• Role of cytokines in the pathophysiology of acute graft-versus-host disease (GVHD): are serum/plasma cytokines potential biomarkers for diagnosis of acute GVHD following allogeneic hematopoietic cell transplantation (Allo-HCT)?

  2012cites this paper
• allogeneic hematopoietic stem cell transplant recipients: a cohort study invasive fungal infections in -Candida other emerging risk factors of non Infliximab use in patients with severe graft-versus-host disease and

  2011cites this paper
• marrow transplantation graft-versus-host disease after allogeneic HLA-identical sibling bone secreting T-helper cell precursors in patients with and without acute Quantitative assessment of posttransplant host-specific interleukin-2-

  2011cites this paper
• Relação entre polimorfismos genéticos e níveis de citocinas com a doença do enxerto contra o hospedeiro aguda no transplante alogênico de células-tronco hematopoiéticas

  2010cites this paper
• Plasma biomarkers in GVHD: a new era?

  2009cites this paper
• A biomarker panel for acute graft-versus-host disease.

  2009cites this paper
• Plasma biomarkers in graft-versus-host disease: a new era?

  2009cites this paper
• T-helper-1 (Th1) and Th2 cytokines after allogeneic hematopoietic stem cell transplantation (allo-HSCT).

  2008cites this paper
• Immunosuppressive effect of ER-38925, a retinoic acid receptor subtype α-selective agonist, in mouse models of human graft-vs-host disease.

  2008cites this paper
• Fungal Infections Complicating Tumor Necrosis Factor α Blockade Therapy

  2008cites this paper
• Fungal infections complicating tumor necrosis factor alpha blockade therapy.

  2008cites this paper
• Anti-tumor necrosis factor-a for the treatment of steroid-refractory acute graft-versus-host disease.

  2007cites this paper
• Mechanisms of graft versus host disease produced by small bowel transplantation

  2007cites this paper
• Serum‐soluble tumor necrosis factor receptor 2 (sTNF‐R2) level determines clinical outcome in patients with aggressive non‐Hodgkin's lymphoma

  2006cites this paper
• Immune Reconstitution and Tolerance after Allogeneic Hematopoietic Stem Cell Transplantation

  2003influential citation
• Phase 1-11 Trial of a Monoclonal Anti-Tumor Necrosis Factor a Antibody for the Treatment of Refractory Severe Acute Graft-Versus-Host Disease

  2003cites this paper
• Bedeutung von Zytokinen im Aszites und Serum

  2003cites this paper
• Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study.

  2003cites this paper
• Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.

  2002cites this paper
• des Universitätsklinikums Hamburg-Eppendorf Medizinische Klinik und Poliklinik I

  2002cites this paper
• ALLOJENEİK KÖK HÜCRE TRANSPLANTASYONU SONRASI Th1/Th2 SİTOKİNLER VE SOLUBL ADEZYON MOLEKÜLLERİ: KÖK HÜCRE KAYNAĞI VE DALTEPARİN KULLANIMININ ETKİLERİ

  2001cites this paper
• Kinetic analysis of cytokine gene expression in patients with GVHD after donor lymphocyte infusion

  2001cites this paper
• Neutralization of tumor necrosis factor-alpha action delays but does not prevent lung injury induced by alloreactive T helper 1 cells.

  2000cites this paper
• Intracellular cytokine production and cytokine receptor interaction of cord mononuclear cells: relevance to cord blood transplantation

  1999cites this paper
• Idiopathic pneumonia after bone marrow transplantation: cytokine activation and lipopolysaccharide amplification in the bronchoalveolar compartment.

  1999cites this paper
• Dysregulation of inflammatory cytokines in unrelated bone marrow transplantation.

  1998cites this paper
• TNF-α inhibitors and rheumatoid arthritis

  1998cites this paper
• Expert Opinion on Therapeutic Patents

  1998cites this paper
• Monoclonal Antibodies in the Treatment of Steroid‐Resistant Acute Graft‐versus‐Host Disease

  1998cites this paper
• Plasma cytokines in graft vs host disease and complications following bone marrow transplantation.

  1997cites this paper
• Graft-versus-host-disease-associated lymphoid hypoplasia and B cell dysfunction is dependent upon donor T cell-mediated Fas-ligand function, but not perforin function.

  1997cites this paper
• TNF receptor p55 controls early acute graft-versus-host disease.

  1997cites this paper
• Involvement of TNF-alpha secreting macrophages in lethal forms of human graft-versus-host disease

  1997cites this paper
• Comparative cytokine production by in vitro stimulated mononucleated cells from cord blood and adult blood.

  1997cites this paper
• Graft-vs.-host disease.

  1997cites this paper
• Prevention and treatment of acute graft-versus-host disease: the old and the new. A report from The Eastern Cooperative Oncology Group (ECOG)

  1997cites this paper
• Increased plasma level of vascular endothelial glycoprotein thrombomodulin as an early indicator of endothelial damage in bone marrow transplantation.

  1996cites this paper
• Serum concentration of the soluble interleukin-2 receptor for monitoring acute graft-versus-host disease.

  1996cites this paper
• Is there a role for tumor necrosis factor-alpha (TNF-alpha) in oral lichen planus?

  1996cites this paper
• Soluble tumor necrosis factor (sTNF) receptors: a possible prognostic marker for bone marrow transplantation-related complications.

  1996cites this paper
• Graft-versus-leukemia effect and its clinical implications.

  1996cites this paper
• Serum interleukin-12 levels in patients undergoing allogeneic or autologous bone marrow transplantation.

  1996cites this paper
• Graft Versus Host Response: Clinical and Biological Relevance After Transplantation of Solid Organs

  1996cites this paper
• ELEVATED INFLAMMATORY CYTOKINE LEVELS IN BONE MARROW GRAFT REJECTION

  1995cites this paper
• IL-7 drives donor T cell proliferation and can costimulate cytokine secretion after MHC-matched allogeneic bone marrow transplantation.

  1995cites this paper
• THE TISSUE EXPRESSION OF CYTOKINES IN HUMAN ACUTE CUTANEOUS GRAFT‐VERSUS‐HOST DISEASE

  1995cites this paper
• CD8+ activated T lymphocytes produce an in vitro skin graft-versus-host reaction in an organotypic skin culture model.

  1995cites this paper
• Sequential use of three monoclonal antibodies in corticosteroid-resistant acute GVHD: a multicentric pilot study including 15 patients.

  1995cites this paper
• New and experimental therapies for treating graft-versus-host disease.

  1995cites this paper
• Cytokine gene expression after allogeneic bone marrow transplantation.

  1995cites this paper
• Functional hyperactivity of monocytes after bone marrow transplantation: possible relevance for the development of post-transplant complications or relapse.

  1995cites this paper
• TNF alpha levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHD.

  1995cites this paper
• Interleukin-1 or tumor necrosis factor-alpha antagonists do not inhibit graft-versus-host disease induced across the major histocompatibility barrier in mice.

  1995cites this paper
• In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.

  1995cites this paper
• The role of alloreactive cytotoxic and lymphokine-secreting T lymphocytes in the development of acute graft-versus-host disease.

  1994cites this paper
• Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease.

  1994cites this paper
• The role of tumor necrosis factor and interferon gamma in graft-versus-host disease and related immunodeficiency.

  1994cites this paper
• Cytokine gene expression by concanavalin A-stimulated peripheral mononuclear cells after bone marrow transplantation: an indicator of immunological abnormality due to chronic graft-versus-host disease.

  1994cites this paper
• High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells

  1994cites this paper
• Cells of Th2 cytokine phenotype prevent LPS-induced lethality during murine graft-versus-host reaction. Regulation of cytokines and CD8+ lymphoid engraftment.

  1994cites this paper
• Influence of Growth Suppression of Intestinal Bacteria on the Risk of Acute Graft vs Host Disease After Sibling Marrow Transplantation

  1994cites this paper
• Pentoxifylline inhibits tumor necrosis factor-α-mediated cytotoxicity and cytostasis in L929 murine fibrosarcoma cells

  1994cites this paper
• Acute‐phase response, interleukin‐6, and alteration of cyclosporine pharmacokinetics

  1994cites this paper
• Serum concentrations of tumour necrosis factor-alpha during chemotherapy-induced leukopenia in patients with acute leukaemia and bacterial infections.

  1994cites this paper
• Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease.

  1994cites this paper
• Cytokine Detection and Modulation in Acute Graft vs. Host Disease in Mice

  1994cites this paper
• Pentoxifylline inhibits tumor necrosis factor-alpha-mediated cytotoxicity and cytostasis in L929 murine fibrosarcoma cells.

  1994cites this paper
• Relevance of tumor necrosis factor to graft-versus-host disease after small bowel transplantation

  1993cites this paper
• Analysis of enteropathy induced by tumour necrosis factor alpha.

  1993cites this paper
• Quantitative assessment of posttransplant host-specific interleukin-2-secreting T-helper cell precursors in patients with and without acute graft-versus-host disease after allogeneic HLA-identical sibling bone marrow transplantation.

  1993cites this paper
• Measurement of recipient-specific alloreactivity: is GVHD predictable?

  1993cites this paper
• Constant intravenous pentoxifylline infusions in allogeneic marrow transplant recipients: results of a dose escalation study.

  1993cites this paper
• Current thoughts on the pathogenesis of graft versus host disease.

  1993cites this paper
• Relevance of tumor necrosis factor to graft‐versus‐host disease after small bowel transplantation

  1993cites this paper
• Serum cytokine levels in patients undergoing bone marrow transplantation.

  1993cites this paper
• Cytokine gene expression in peripheral blood mononuclear cells during graft‐versus‐host disease after allogeneic bone marrow transplantation

  1993cites this paper
• Tumor necrosis factor, other cytokines and disease.

  1993cites this paper
• Graft-versus-host disease in bone marrow transplantation: experimental, laboratory, and clinical contributions of the last few years.

  1993cites this paper
• Cytokine gene expression in peripheral blood mononuclear cells during graft-versus-host disease after allogeneic bone marrow transplantation.

  1993cites this paper
• Raised levels of tumor‐necrosis factor alpha (TNFα) in cardiac transplant patients

  1993cites this paper
• TUMOR NECROSIS FACTOR, OTHER CYTOKINES AND

  1993cites this paper
• Serum interleukin-3 levels following autologous or allogeneic bone marrow transplantation: effects of T-cell depletion, blood stem cell infusion, and hematopoietic growth factor treatment.

  1993cites this paper
• Intestinal graft-versus-host disease

  1992cites this paper
• Regulation of tumor necrosis factor-alpha production and gene expression in monocytes.

  1992cites this paper
• Tumor necrosis factor-alpha associated with chronic graft-versus-host disease in bone marrow transplantation recipients.

  1992cites this paper
• Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease

  1992cites this paper
• Serum levels and receptor expression of tumor necrosis factor-alpha following human allogeneic and autologous bone marrow transplantation.

  1992cites this paper
• Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings.

  1992cites this paper
• THE RELATIONSHIP OF SERUM IL‐6 LEVELS TO ACUTE GRAFT‐VERSUS‐HOST DISEASE AND HEPATORENAL DISEASE AFTER HUMAN BONE MARROW TRANSPLANTATION

  1992cites this paper
• Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease.

  1992cites this paper